Evidence map›Paper›PMID 26358154›Full record

ArticleCell death and differentiation2016

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation.

M Charni, A Molchadsky, I Goldstein, H Solomon, P Tal, N Goldfinger, P Yang, Z Porat, G Lozano, V Rotter

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Uterine fibroids show evidence of shared genetic architecture with blood pressure traits.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

M CharniDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
A MolchadskyDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
I GoldsteinDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
H SolomonDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
P TalDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
N GoldfingerDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
P YangDepartment of Genetics, UT MD Anderson Cancer Center, Houston, TX, USA.
Z PoratThe Flow Cytometry Unit, Life Sciences Faculty, Weizmann Institute of Science, Rehovot, Israel.
G LozanoDepartment of Genetics, UT MD Anderson Cancer Center, Houston, TX, USA.
V RotterDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Weizmann Institute of Science · ILThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

The tumor-suppressor p53 is a transcription factor that prevents cancer development and is involved in regulation of various physiological processes. This is mediated both by induction of cell cycle arrest and apoptosis and by controlling the expression of a plethora of target genes, including secreted proteins. It has been demonstrated that p53 may exert its effect in non-cell-autonomous manner by modulating the expression of genes that encode for secreted factors. In this study, we utilized our microarray data to identify and characterize novel p53 target genes expressed in human liver cells and associated with steroid hormones processing and transfer. We identified the steroid hormones binding factors, sex hormone-binding globulin (SHBG), corticosteroid-binding globulin (CBG) and cytochrome P450 family 21 subfamily A polypeptide 2, as novel p53 target genes. Their expression and secretion was increased following p53 activation in various hepatic cells. We observed that p53 wild-type mice exhibited higher levels of CBG compared with their p53 null counterparts. We demonstrated that the induction of the steroid hormones binding factors can be mediated by binding to specific p53 responsive elements within their promoters. In addition, utilizing conditioned medium experiments we have shown that p53-dependent induction of SHBG secretion from liver cells enhances apoptosis of breast cancer cells. Moreover, depletion of SHBG abolished the induction of breast cancer cells death. The newly identified p53 target genes suggest a novel non-cell-autonomous tumor-suppressive regulation mediated by p53 that is central for maintaining organism homeostasis.

Indexed as

Transcriptional ActivationAnimalsApoptosisHep G2 CellsHumansLiverMCF-7 CellsMice, Inbred C57BLMice, KnockoutSex Hormone-Binding GlobulinSteroid 21-HydroxylaseTranscortinTranscription, GeneticTumor Suppressor Protein p53CYP21A2 protein, humanSex Hormone-Binding GlobulinSteroid 21-HydroxylaseTP53 protein, humanTranscortinTumor Suppressor Protein p53

Identifiers

PMID26358154
PMCPMC5072444
OpenAlexW2233715842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.